Primary immunodeficiency (PID) diseases occur in about 1 in every 1200 individuals and are associated with recurrent infections and several comorbidities that contribute to its substantial morbidity ...
If you have an immunodeficiency related to certain infections, inflammatory diseases, or autoimmune disorders, you may have heard about an infusion treatment called intravenous immunoglobulin, or IVIG ...
Two studies discussed the feasibility of different parameters for the infusion of a product for patients with primary immunodeficiency disorder in abstracts prepared for the American Academy of ...
The TAK-881-3001 clinical trial evaluated the PK, efficacy, safety, tolerability and immunogenicity of TAK-881 in adults and pediatric patients aged 2 years and older with PID previously treated with ...
Please provide your email address to receive an email when new articles are posted on . SAN ANTONIO — Cutaquig provided safe and effective dosing flexibility for patients with primary immunodeficiency ...
Plasma-derived immunoglobulin replacement therapy (IRT) is one of the mainstays of supportive management for many inborn errors of immunity, primarily those affecting the adaptive immune system which ...
MAHWAH, N.J.--(BUSINESS WIRE)-- KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development, manufacturing, and ...
“The approval of GAMMAGARD LIQUID ERC reinforces our commitment to supporting individualized treatment approaches for people with primary immunodeficiency, including a therapeutic option that has the ...
Gammagard Liquid is a brand-name infusion prescribed for certain rare immune conditions. Gammagard Liquid contains the active ingredient immune globulin (human). Gammagard Liquid has boxed warnings. A ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results